Cargando…

Successful defibrillation testing in patients undergoing elective subcutaneous implantable cardioverter-defibrillator generator replacement

AIMS: After implantation of a subcutaneous implantable cardioverter-defibrillator (S-ICD), a defibrillation test (DFT) is performed to ensure that the device can effectively detect and terminate the induced ventricular arrhythmia. Data on DFT efficacy at generator replacement are scarce with a limit...

Descripción completa

Detalles Bibliográficos
Autores principales:	de Veld, Jolien A, Pepplinkhuizen, Shari, van der Stuijt, Willeke, Quast, Anne-Floor B E, Olde Nordkamp, Louise R A, Kooiman, Kirsten M, Wilde, Arthur A M, Smeding, Lonneke, Knops, Reinoud E
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2023
Materias:	Clinical Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10325005/ https://www.ncbi.nlm.nih.gov/pubmed/37379530 http://dx.doi.org/10.1093/europace/euad184

Ejemplares similares

High shock impedance during subcutaneous implantable defibrillator generator replacements: Authors’ reply
por: van der Stuijt, Willeke, et al.
Publicado: (2021)

Complications related to elective generator replacement of the subcutaneous implantable defibrillator
por: van der Stuijt, Willeke, et al.
Publicado: (2020)

Long‐term follow‐up of the two‐incision implantation technique for the subcutaneous implantable cardioverter‐defibrillator
por: van der Stuijt, Willeke, et al.
Publicado: (2020)

Defibrillation testing during implantation of the subcutaneous implantable cardioverter-defibrillator: a necessary standard or becoming redundant?
por: van der Stuijt, W., et al.
Publicado: (2020)

Comparison of complications and shocks in paediatric and young transvenous and subcutaneous implantable cardioverter-defibrillator patients
por: Quast, A. B. E., et al.
Publicado: (2018)

First experience with the wearable cardioverter defibrillator in the Netherlands
por: Knops, R. E., et al.
Publicado: (2011)

Who benefits from implantable cardioverter defibrillator therapy, and who pays the price?
por: Olde Nordkamp, L. R. A., et al.
Publicado: (2013)

Accuracy and clinical relevance of the single-lead Apple Watch electrocardiogram to identify atrial fibrillation
por: Pepplinkhuizen, Shari, et al.
Publicado: (2022)

Subcutaneous implantable cardioverter-defibrillators: long-term results of the EFFORTLESS study
por: Lambiase, Pier D, et al.
Publicado: (2022)

The learning curve associated with the introduction of the subcutaneous implantable defibrillator
por: Knops, Reinoud E., et al.
Publicado: (2016)

Predictors of Elevated Defibrillation Threshold with the Subcutaneous Implantable Cardioverter-defibrillator
por: Do, Khuyen, et al.
Publicado: (2017)

The Subcutaneous Implantable Cardioverter-Defibrillator: Not For All
por: Nair, Krishnakumar, et al.
Publicado: (2014)

The subcutaneous implantable cardioverter-defibrillator should be considered for all patients with an implantable cardioverter-defibrillator indication
por: Tan, Jian Liang, et al.
Publicado: (2022)

Comparative outcomes of subcutaneous and transvenous cardioverter-defibrillators
por: Liang, Jin-Jun, et al.
Publicado: (2019)

Outpatient treatment with the wearable cardioverter defibrillator: clinical experience in two Dutch centres
por: Quast, A. F. B. E., et al.
Publicado: (2017)

Subcutaneous implantable cardioverter-defibrillator placement in a patient with a preexisting transvenous implantable cardioverter-defibrillator
por: Jazayeri, Mohammad-Ali, et al.
Publicado: (2017)

Subcutaneous Implantable Cardioverter Defibrillator: Early Experience
por: Souza, Fernando Sérgio Oliva, et al.
Publicado: (2017)

Noise caused by involuntary muscle response may inhibit detection of ventricular fibrillation during defibrillation testing
por: Baalman, Sarah W.E., et al.
Publicado: (2019)

Intraoperative Defibrillation Testing of Subcutaneous Implantable Cardioverter‐Defibrillator Systems—A Simple Issue?
por: Frommeyer, Gerrit, et al.
Publicado: (2016)

Successful defibrillation verification in subcutaneous implantable cardioverter‐defibrillator recipients by low‐energy shocks
por: Biffi, Mauro, et al.
Publicado: (2019)

Induced atrial fibrillation during defibrillation test on implantation of subcutaneous implantable cardioverter defibrillator
por: Kim, Ki-Hun, et al.
Publicado: (2020)

Implantation of a subcutaneous implantable cardioverter-defibrillator in a patient with epicardial defibrillation patches
por: Yoshizawa, Reisuke, et al.
Publicado: (2021)

The subcutaneous implantable cardioverter defibrillator––review of the recent data
por: Westerman, Stacy B, et al.
Publicado: (2018)

Subcutaneous Implantable Cardioverter-Defibrillator Shock: Appropriate or Inappropriate?
por: Ip, James E.
Publicado: (2017)

An “UninTENSional” Subcutaneous Implantable Cardioverter-defibrillator Shock
por: Turner, Suzette L., et al.
Publicado: (2018)

Inappropriate subcutaneous implantable cardioverter-defibrillator shocks for bradycardia
por: Chua, Kelvin C.M., et al.
Publicado: (2021)

Painful detour of subcutaneous implantable cardioverter-defibrillator lead
por: Bisson, Jasmine, et al.
Publicado: (2022)

Subcutaneous Implantable Cardioverter Defibrillator: A Contemporary Overview
por: Guarracini, Fabrizio, et al.
Publicado: (2023)

The Subcutaneous Implantable Cardioverter-Defibrillator: A Patient Perspective
por: Nesti, Martina, et al.
Publicado: (2023)

Impairment of Quality of Life in Patients with Implanted Subcutaneous Cardioverter Defibrillator (S-ICD) Compared to Implanted Transvenous Cardioverter Defibrillator Therapy
por: Thienel, Manuela, et al.
Publicado: (2022)

Optimizing patient selection for primary prevention implantable cardioverter-defibrillator implantation: utilizing multimodal machine learning to assess risk of implantable cardioverter-defibrillator non-benefit
por: Kolk, Maarten Z H, et al.
Publicado: (2023)

A sustained ventricular tachycardia overlooked by subcutaneous implantable cardioverter-defibrillator but recognized by co-implanted transvenous implantable cardioverter defibrillator
por: Goto, Kentaro, et al.
Publicado: (2020)

Implantable cardioverter-defibrillators /
Publicado: (1994)

Shoulder Joint Dislocation as an Unusual Complication of Defibrillation Threshold Testing Following Subcutaneous Implantable Cardioverter-Defibrillator Implantation
por: Noheria, Amit, et al.
Publicado: (2014)

The Italian subcutaneous implantable cardioverter-defibrillator survey: S-ICD, why not?
por: Botto, Giovanni Luca, et al.
Publicado: (2017)

Multicentre early experience with totally subcutaneous cardioverter-defibrillators in Poland
por: Kaczmarek, Krzysztof, et al.
Publicado: (2019)

The subcutaneous implantable cardioverter-defibrillator: A tertiary center experience
por: Khazen, Cesar, et al.
Publicado: (2019)

The subcutaneous implantable cardioverter-defibrillator should be reserved for niche indications
por: Yang, Yang, et al.
Publicado: (2022)

Atrial pacing–induced oversensing in subcutaneous implantable cardioverter-defibrillator
por: Wharmby, Amy, et al.
Publicado: (2023)

Standard and extended electrocardiographic screening for the subcutaneous implantable cardioverter-defibrillator
por: Lewandowski, M, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_40jkaiq1k1867aoc52ue5ebu8m